PharmaVOICE - 
October 2017
Purchase Issue

In Every Issue
Letter from the Editor
Connected Health At this month’s 2017 Connected Health Conference to [...]
By

Taren Grom, Editor

Upfront
Amgen Foundation Expands the Amgen Biotech Experience The Amgen Foundation [...]
By

PharmaVOICE Staff

HealthTech
Wearable Healthcare: Beyond Smartwatches and Fitness Trackers Trend Watch: Next-gen [...]
By

PharmaVOICE Staff

Innovator’s Corner
Using Electric Fields to Treat Cancer Bill Doyle, Executive Chairman [...]
By

Bill Doyle, Executive Chairman of Novocure

Last Word
Pharma’s Role in the Community John Damonti, President of the [...]
By

John Damonti, President of the Bristol-Myers Squibb Foundation and VP of Corporate Philanthropy at Bristol-Myers Squibb

On The Cover

A Connected Healthcare Life
Three years ago, Verily — then a division of Google X — unveiled its Baseline Project, a collaboration with Duke University and Stanford University to collect health data from healthy people to get a sense of what “normal” looks like. Earlier this year, the group began the process of enrolling 10,000 healthy people, over the [...]
By

Robin Robinson

Features

A Rare Journey: Managing the Regulatory Landscape
In 1983, Congress passed the Orphan Drug Act, bringing with it the opportunity to advance the development of drugs for rare diseases. Since that time, the Food and Drug Administration (FDA) has approved more than 550 products to treat rare diseases. The FDA established the Office of Orphan Products Development (OOPD) with a mission to [...]
By

Kim Ribbink

The Battle Against Infectious Disease
Epidemics of infectious diseases are a real and dangerous threat. Nowhere in the world have infectious diseases been addressed adequately to become a small portion of illness and death. The Ebola and Zika public health emergencies have brought to light that we are unprepared to detect, prevent, and treat pandemic infections. These outbreaks cost thousands [...]
By

Denise Myshko

The Launch Pad Preparing for Product Launch
Launching a pharmaceutical product has never been easy, but in years past it was certainly simpler. The days of focusing singularly on high-decile prescribing docs and sending out an army of sales reps are a distant memory. Today’s marketers must establish a value story for physicians, patients, and payer stakeholders, and communicate that value effectively. [...]
By

Robin Robinson

Solutions for Clinical Sites
Clinical study sites are transforming their technology infrastructures with the adoption of electronic medical records (EMRs). But while EMRs improve treatment-related tasks in healthcare settings, they have not helped to reduce the burden of clinical trial studies on the sites. A May 2017 survey shows that study sites remain burdened with mundane administrative tasks, such [...]
By

Denise Myshko

What Do Millennials Want?
So much has been written about the Millennials. With the exception of Baby Boomers, Millennials are the most talked about and studied generation. Born roughly between 1981 and 1997 (depending on which survey you look at), this generation, we are told, thinks and behaves differently. Some 80 million strong, this generation grew up at a [...]
By

Denise Myshko

SHOWCASE FEATURE: Patient Solutions: Responding to the Needs of the Savvy Patient
Responding to the Needs of the Savvy Patient When healthcare IT strategist Leonard Kish referred to patient engagement as the blockbuster drug of the century, he tapped into an important realization: that the patient has to be at the center of everything a pharmaceutical company does. Today’s patients are increasingly savvy and engaged in their [...]
By

PharmaVOICE Staff

A Roadmap for Patient-Centric Patient Support Programs
Patient-centricity is widely embedded into the mission statements and values of biopharma organizations. It gives purpose and urgency to efforts across research, development, and commercialization. Yet patient-centricity often is vaguely defined — making the goal hard to achieve. Teams striving for patient-centricity could use a roadmap. A workgroup involving advocates and caregivers recently published an [...]
By

Lauren Walrath, Director of Strategy and Business Development, Atlantis Healthcare, US

Precision Medicine Meets Precision Patient Support
In the value-driven healthcare environment, orphan drug manufacturers are becoming increasingly aware that improving adherence requires a new approach to patient understanding and support. Take for example the required lifestyle, nutritional or physical modifications often necessary for patient compliance — behaviors that are difficult to influence, track or control without proper patient insights and ongoing [...]
By

Kathi Henson, Chief Patient Service Officer, Dohmen Life Science Services

Impact Patient Outcomes Without Talking to the Patient
Patient marketers are used to providing valuable patient services and information directly to patients. But if the goal is to accelerate patient outcomes, the needs of the caregiver should also be addressed. Patient marketers know that caregivers play an important part in patients’ lives, but they often don’t see caregivers as having a direct impact [...]
By

Andi Weiss, Lead behaviorist, Partnerships and Advocacy, MicroMass Communications, Inc.

The Connected Consumer
At some point during the far-off days of the Carter administration, Carnegie Mellon expanded its Computer Science department, leaving programmers farther away from the department’s only Coke machine. So rather than trek down a couple of floors only to find an empty vending machine, or worse, a machine recently loaded with still-warm soda, they figured [...]
By

Johanna Skilling, Head of Planning, Ogilvy CommonHealth Worldwide

SHOWCASE FEATURE: Supply Chain: The Supply Chain of the Future
Analysts say reimagining processes to take advantage of advanced connectivity can be a supply chain differentiator in the future. The pharmaceutical supply chain, one of the most complex in any industry silo, is also one of the most inefficient and ill-equipped to cope with products in the pipeline, according to analysts at PwC. The pharm [...]
By

PharmaVOICE Staff

Driving Access and Efficiency with a Direct-to-Physician Sampling Program
For commercial teams at pharmaceutical companies, reaching physicians with product messaging has never been more challenging. In fact, according to 2016 research from AccessMonitor1, only 44% of physicians, were considered accessible to pharmaceutical sales representatives — a decline from 80% in 2008. And one in five of all physicians “severely” limit access to reps. Given [...]
By

Joel wayment, VP, Operations, Cardinal Health 3PL

FEEDBACK